CM Management, LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
CM Management, LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,803,000
+20.8%
45,000
+12.5%
1.92%
+53.2%
Q1 2022$1,492,000
+7.0%
40,000
+14.3%
1.25%
+19.0%
Q4 2021$1,394,000
+24.9%
35,000
+16.7%
1.05%
+26.6%
Q3 2021$1,116,000
-12.0%
30,0000.0%0.83%
-9.2%
Q2 2021$1,268,000
+7.1%
30,000
+20.0%
0.92%
+4.1%
Q1 2021$1,184,000
-22.4%
25,0000.0%0.88%
-37.8%
Q4 2020$1,526,00025,0001.42%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders